CME Presentations

Spinal Muscular Atrophy


Presentations


Speakers

  • Melissa Gibbons, MS, CGC

    Melissa Gibbons, MS, CGC

    Melissa Gibbons, MS, CGC

    Certified Genetic Counselor

    Melissa Gibbons, MS, CGC, is a certified genetic counselor and assistant professor at the University of Colorado School of Medicine and Children’s Hospital Colorado in Aurora, where she specializes in neurogenetics and neuromuscular conditions. Her professional interest includes increasing awareness of neuromuscular conditions through education of providers and families. Melissa is an advocate for increased awareness of the benefits of carrier testing, prenatal diagnosis, and newborn screening to allow for earlier access to approved and research therapies.
  • Lizbeth McCarthy, MD

    Lizbeth McCarthy, MD

    Lizbeth McCarthy, MD

    Director of Genetics and Ultrasound

    Liz McCarthy, MD, is director of the Genetics and Ultrasound Program at Denver Health in Colorado. She grew up in Berkeley, California, and then attended the University of Colorado at Boulder where she earned her bachelor’s in biology. Dr McCarthy received her medical degree, completed an OB/GYN residency, and completed a fellowship in clinical genetics at University of Colorado. She lives in Louisville, Colorado with her husband, two dogs, and 19-year-old daughter. Dr McCarthy enjoys running, skiing, and just started golf lessons.
  • Julie A. Parsons, MD

    Julie A. Parsons, MD

    Julie A. Parsons, MD

    Professor of Clinical Pediatrics and Neurology

    Julie A. Parsons, MD, is a professor of clinical pediatrics and neurology at the University of Colorado School of Medicine in Aurora, the Haberfeld Family Endowed Chair in Pediatric Neuromuscular Disorders, and co-director of the neuromuscular clinic at Children’s Hospital Colorado. Her clinical interests include neuromuscular diseases such as muscular dystrophies, spinal muscular atrophy (SMA), and myotonic dystrophies. She is an active participant and principal investigator for many clinical trials, and is a member of organizations that include the Child Neurology Society and the American Academy of Neurology. Dr Parsons earned her MD from the University of Colorado School of Medicine, followed by residencies in pediatrics and child neurology and a neuromuscular medicine fellowship.

CME Information

Collaborative Care in SMA: Evolving Roles for Neurologists, Ob‐Gyns, PCPs, and Counselors


PIM Logo PQH Logo

LEARNING OBJECTIVES

After completing this activity, the participant should be better able to:
  • Discuss how DMTs are expected to change the course of SMA disease and result in new phenotypes across the spectrum of patients
  • Explain how new SMA phenotypes will lead to expansion of the roles of PCPs and Ob‐Gyns in the management of SMA, from genetic carrier identification to early diagnosis and adult‐care transitions
  • Describe issues that may arise in patients with SMA who transition from pediatric to adult care and develop strategies on how those issues can effectively be addressed, with a focus on reproductive care
Jointly provided by Postgraduate Institute for Medicine (PIM) and PlatformQ Health Education, LLC (PQHE) working in collaboration with the National Organization for Rare Disorders, Inc. (NORD).

ACKNOWLEDGEMENT

This activity is supported by educational grants from Biogen, MRC Holland, and Novartis Gene Therapies, Inc.

TUITION

Complimentary

JointlyAccreditedProvider Logo

JOINT ACCREDITATION STATEMENT

In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and PlatformQ Health Education, LLC. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

LIVE CREDIT DESIGNATION STATEMENTS

Physician Continuing Medical Education

The Postgraduate Institute for Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ENDURING CREDIT DESIGNATION STATEMENTS

Physician Continuing Medical Education

The Postgraduate Institute for Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

DATE OF RELEASE/EXPIRATION

Live Activity

Wednesday, July 28, 2021, from 4:00pm – 5:00pm ET

Enduring Material

The enduring material will be available from July 28, 2021 to July 28, 2022

TARGET AUDIENCE

This activity is intended for pediatric neurologists, neurologists, pediatricians, neuromuscular specialists, pulmonologists, pediatric gastroenterologists, primary care physicians, Ob-Gyns, advanced practice clinicians (NPs, PAs), physical therapists/occupational therapists, nutritionists, genetic counselors, and other HCPs involved in the care of patients with SMA.

ESTIMATED TIME TO COMPLETE

This activity consists of 1 session which should take approximately 1 hour to complete.

METHOD OF PARTICIPATION

There are no fees to participate in this activity. To participate in the activity, go to www.NeuroSeriesLive.com. To receive credit, participants must (1) read the target audience, learning objectives, and disclosure statements, (2) complete the educational activity online, and (3) complete the post-test and activity evaluation. To receive AMA PRA Category 1 Credits™, participants must receive a minimum score of 70% on the post-test.

HARDWARE/SOFTWARE REQUIREMENTS

Participants will need a computer with a recent version of Adobe Flash installed, as well as an internet connection sufficient for streaming media.

DISCLOSURE OF CONFLICTS OF INTEREST

Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Name of Faculty or Presenter Reported Financial Relationship
Julie A. Parsons, MD
Haberfeld Family Endowed Chair in Pediatric Neuromuscular Disorders
Professor of Clinical Pediatrics and Neurology
University of Colorado School of Medicine
Children's Hospital Colorado
Consulting Fees: Biogen, Genentech Roche, Novartis, Scholar Rock
Contracted Research: Biogen, Novartis, PTC Therapeutics, Scholar Rock
Lizbeth McCarthy, MD
Director of Genetics and Ultrasound
Denver Health
Nothing to disclose
Melissa Gibbons, MS, CGC
Assistant Professor; Certified Genetic Counselor
University of Colorado School of Medicine
Children's Hospital Colorado
Consulting Fees: Novartis Advisory Board, Speaker at Biogen Medical Forum
Other: Cure SMA Medical Advisory Board

The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Name of Planner Reported Financial Relationship
Carole Drexel
Medical Director
PlatformQ Health Education, LLC
None

The PIM planners and managers have nothing to disclose.

The following PlatformQ Health Education, LLC planner, Alissa Yost, hereby states that she or her spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.

DISCLOSURE OF UNAPPROVED/OFF LABEL USE (if applicable):

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

DISCLAIMER:

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

CONTACT INFORMATION

Accreditation Support: Please contact the Postgraduate Institute for Medicine at inquiries@pimed.com.

Technical Support: For any technical issues or issues with your CME Certificate, please contact NeuroSeriesLive.com at 877-394-1306 or at Support@NeuroSeriesLive.com.